admin3

CARDIOCOMM SOLUTIONS TO ISSUE SHARES UNDER ONLINE MARKETING AND AWARENESS PROGRAM

by

TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE: EKG) (“CardioComm” or the “Company”), a leading global medical provider of consumer heart monitoring and electrocardiogram (“ECG”) acquisition and management software solutions, announced that it has made its second issuance of shares under its online marketing and awareness program with AGORA Internet Relations Corp. (“AGORACOM”). The Company … Read more

CARDIOCOMM SOLUTIONS LAUNCHES NEW GEMS™ MOBILE UNIVERSAL ECG APP EXPANDING ECG REPORTING SERVICES ACROSS GLOBAL MARKETS

by

TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE: EKG) (“CardioComm” or the “Company”), a leading global medical provider of consumer heart monitoring and electrocardiogram (“ECG”) acquisition and management software solutions, announces the release of a new version of the Company’s recently cleared US Food and Drug Administration (“FDA”) GEMS™ Mobile ECG app. The new version … Read more

CARDIOCOMM SOLUTIONS LEVERAGES THE GEMSTM MOBILE ECG APP TO BRING A THIRD FDA CLEARED HEARTCHECK™ BRANDED ECG DEVICE TO THE US CONSUMER MARKETS

by

TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE: EKG) (“CardioComm” or the “Company”), a leading global medical provider of consumer heart monitoring and electrocardiogram (“ECG”) acquisition and management software solutions, confirms the start of an OEM co-marketing agreement for the HeartCheck™ Palm handheld ECG device, the Company’s newest GEMS™ Mobile ECG app (“GEMSTM Mobile”) enabled … Read more

CARDIOCOMM SOLUTIONS RELEASES REMOTE 12-LEAD ECG TELEMED SOLUTION WITH ARRYTHMIA DETECTION AND ECG READING SERVICES

by

TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE: EKG) (“CardioComm” or the “Company”), a leading global medical provider of consumer heart monitoring and electrocardiogram (“ECG”) acquisition and management software solutions, has released GlobalCardio 12 FLEX (“GC12 FLEX”), a complete remote 12-lead ECG acquisition and reading solution. GC12 FLEX has been developed for use by clinics … Read more

CARDIOCOMM SOLUTIONS PREPARES NEW FDA APPLICATIONS FOR DIRECT-TO-CONSUMER AND PHYSICIAN USE CARDIAC ARRHYTHMIA ALGORHYTHMS

by

TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE: EKG) (“CardioComm” or the “Company”), a leading global medical provider of consumer heart monitoring and electrocardiogram (“ECG”) acquisition and management software solutions, is preparing US Food and Drug Administration (“FDA”) 510(k) Class II medical device clearance applications for new arrhythmia detection algorithms. The main application will be … Read more

INNOVATION CONTINUES AS THE FDA CLEARS CARDIOCOMM SOLUTIONS’ NOVEL ECG SMARTPHONE APP AND HEARTCHECK™ DEVICE FOR DIRECT TO CONSUMER SALES

by

TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE: EKG) (“CardioComm” or the “Company”), a leading global medical provider of consumer heart monitoring and electrocardiogram (“ECG”) acquisition and management software solutions, has received approval from the US Food and Drug Administration (“FDA”) for the over-the-counter (“OTC”) sales and marketing of their device agnostic GEMS™ Mobile smartphone … Read more

CARDIOCOMM SOLUTIONS ENGAGES US LAW FIRM TO ADDRESS LICENSING AND IP OPPORTUNITIES

by

TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE: EKG) (“CardioComm” or the “Company”), a leading global medical provider of consumer heart monitoring and electrocardiogram (“ECG”) acquisition and management software solutions, confirms it has retained Whiteford, Taylor & Preston L.L.P. to assist in software licensing and intellectual property business matters on a go forward basis. Whiteford, … Read more

CARDIOCOMM SOLUTIONS NOW OFFERS A SMARTPHONE CONNECTED FDA CLEARED 12 LEAD ECG BELT UNDER A NEW CO-MARKETING AGREEMENT

by

TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE: EKG) (“CardioComm” or the “Company”), a leading global medical provider of consumer heart monitoring and electrocardiogram (“ECG”) acquisition and management software solutions, confirms it has entered into a device technology relationship for the co-marketing and US sales of a Smartphone connected 12 lead ECG wearable device. The … Read more

CARDIOCOMM SOLUTIONS’ HEARTCHECK™ DEVICE ENTERS FINAL FDA REVIEW PHASE

by

TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE: EKG) (“CardioComm” or the “Company”), a leading global medical provider of consumer heart monitoring and electrocardiogram (“ECG”) acquisition and management software solutions, confirms it has completed a request for additional information from the US Food and Drug Administration (“FDA”) for the Company’s premarket notification 510(k), Class II … Read more

CARDIOCOMM SOLUTIONS COMPLETES WORK ON ARRHYTHMIA DETECTION ALGORITHMS WITH ARTIFICIAL INTELLIGENCE-BASED LEARNING

by

TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE: EKG) (“CardioComm” or the “Company”), a global medical provider of consumer heart monitoring and electrocardiogram (“ECG”) acquisition and management software solutions, confirms completion of a six month collaborative project with researchers at the University of Victoria, Canada, leading the way to a release of artificial intelligence (“AI”) … Read more